Time lines for the FDA seem to be under pressure
What we thought might happen looks as though it has eventuated
https://endpoints.news/kalvista-says-fda-delayed-decision-on-heart-drug-citing-heavy-workload/?utm_medium=email&utm_campaign=833%20-%20Makary%20envisions%20next%20big%20leaps%20in%20pharma%20States%20join%20Purdue%20opioid%20deal%20Basic&utm_content=833%20-%20Makary%20envisions%20next%20big%20leaps%20in%20pharma%20States%20join%20Purdue%20opioid%20deal%20Basic+CID_36ae8167a1e208cab159171c0f34c5f6&utm_source=ENDPOINTS%20emails&utm_term=KalVista%20says%20FDA%20delayed%20decision%20on%20HAE%20drug%20citing%20heavy%20workload
![]()
- Forums
- ASX - By Stock
- MSB
- Cell Therapy News/Articles
MSB
mesoblast limited
Add to My Watchlist
0.00%
!
$1.83

Cell Therapy News/Articles, page-19649
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.83 |
Change
0.000(0.00%) |
Mkt cap ! $2.331B |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 122 | $2.00 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.72 | 921 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 122 | 1.995 |
7 | 4599 | 1.935 |
2 | 2393 | 1.840 |
2 | 666 | 1.835 |
2 | 104 | 1.830 |
Price($) | Vol. | No. |
---|---|---|
1.710 | 422 | 1 |
1.715 | 5 | 1 |
1.735 | 11390 | 2 |
1.750 | 1 | 1 |
1.760 | 1523 | 2 |
Last trade - 09.50am 18/06/2025 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online